Position in BLLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,210,148
+$1,216,612 QoQ
Shares Held
18,421
+46.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $13,614,781,147 across 42 Diagnostics & Research names. BLLN ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,763,066 | $5,396,170,760 | |
| 2 | DHR |
Danaher Corp /De/
|
11,348,958 | $2,161,749,507 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,356,103 | $713,906,852 | |
| 4 | A |
Agilent Technologies, Inc.
|
5,185,738 | $688,821,571 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
465,226 | $594,330,857 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
2,707,252 | $523,095,221 | |
| 7 | DGX |
Quest Diagnostics Inc
|
2,460,497 | $521,502,333 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,609,447 | $450,645,160 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,210,148 | 18,421 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $993,536 | 12,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $294,540 | 3,599 | Shares | Defined | 2026-05-27 | |
| No filing history on record for this holder in this stock. | ||||||